Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Multiple Myeloma(MM)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00670631
What this trial is testing

Tandem Transplantation in Multiple Myeloma (MM) Patients With <12 Months of Prior Treatment

Who this might be right for
Multiple Myeloma
Guido Tricot 46
Early research (Phase 1)UnknownNCT02240537
What this trial is testing

Phase I Study of an Oncofetal Antigen Multi-Peptide Immunotherapy in Subjects With Hematologic Cancer

Who this might be right for
Acute Myelogenous Leukemia (AML)Multiple Myeloma (MM)Myelodysplastic Syndrome (MDS)+1 more
Benovus Bio, Inc. 4
Large-scale testing (Phase 3)Active Not RecruitingNCT04483739
What this trial is testing

Isa-KRd vs KRd in Newly Diagnosed Multiple Myeloma Patients Eligible for Autologous Stem Cell Transplantation (IsKia TRIAL)

Who this might be right for
Multiple Myeloma
European Myeloma Network B.V. 302
Testing effectiveness (Phase 2)Study completedNCT00689000
What this trial is testing

Safety and Anti-Disease Activity of CHR-2797 (Tosedostat) in Elderly and/or Treatment Refractory Patients With Acute Myeloid Leukemia (AML) and Multiple Myeloma (MM)

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic SyndromeMultiple Myeloma
Chroma Therapeutics 57
Not applicableEnded earlyNCT02761187
What this trial is testing

An Observational Study of Presentation, Treatment Patterns, and Outcomes in Multiple Myeloma Participants

Who this might be right for
Multiple Myeloma
Takeda 4,253
Not applicableStudy completedNCT00889798
What this trial is testing

Tumor Registry of Lymphatic Neoplasia

Who this might be right for
Non-Hodgkin's Lymphoma (NHL)Chronic Lymphocytic Leukemia (CLL)Multiple Myeloma (MM)
iOMEDICO AG 3,795
Testing effectiveness (Phase 2)Looking for participantsNCT07637578
What this trial is testing

Elranatamab Outpatient Administration in Patients With Relapsed/Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma (MM)Multiple Myeloma RefractoryMultiple Myeloma in Relapse+1 more
SCRI Development Innovations, LLC 46
Post-approval studies (Phase 4)Study completedNCT00434447
What this trial is testing

Long Term Efficacy and Safety of Zoledronic Acid Treatment in Patients With Bone Metastases

Who this might be right for
Bone Neoplasms
Novartis Pharmaceuticals 73
Not applicableEnrolling By InvitationNCT06472830
What this trial is testing

MGUS/MM Awareness and Genetics Insights Campaign (MAGIC) Screening Study

Who this might be right for
Monoclonal Gammopathy of Undetermined Significance
Mayo Clinic 1,000
Testing effectiveness (Phase 2)Study completedNCT00523848
What this trial is testing

Bortezomib, Doxorubicin Hydrochloride Liposome, and Thalidomide as First-line Therapy in Treating Patients With Previously Untreated Stage I, II, or III Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Roswell Park Cancer Institute 46
Testing effectiveness (Phase 2)UnknownNCT05739188
What this trial is testing

Safety and Efficacy of Anti-GPRC5D CAR-T Cells Therapy in the Treatment of r/r MM

Who this might be right for
Multiple Myeloma in RelapseMultiple Myeloma, Refractory
920th Hospital of Joint Logistics Support Force of People's Liberation Army of China 18
Testing effectiveness (Phase 2)Looking for participantsNCT05294055
What this trial is testing

Mecapegfilgrastim With Chemotherapy for Peripheral Blood Stem Cell Mobilization in MM and Lymphoma

Who this might be right for
Multiple MyelomaLymphoma
Institute of Hematology & Blood Diseases Hospital, China 120
Testing effectiveness (Phase 2)Active Not RecruitingNCT05434689
What this trial is testing

COMbination Regimens in MM Post AHCT to elimiNate MRD Utilizing IbERdomide

Who this might be right for
Multiple Myeloma
University of Alabama at Birmingham 80
Testing effectiveness (Phase 2)Study completedNCT00872521
What this trial is testing

Efficacy of Treatment With Bortezomib (in Combination With Doxorubicin and Dexamethasone) in Previously Untreated Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Janssen-Cilag Pty Ltd 107
Not applicableLooking for participantsNCT06559033
What this trial is testing

Determine the Frequency of Variants in the GBA/PSAP Genes in Patients With MM or MGUS

Who this might be right for
Monoclonal Gammopathy of Undetermined SignificanceMyeloma Multiple
University Hospital, Rouen 300
Testing effectiveness (Phase 2)Study completedNCT01370434
What this trial is testing

Two Cycles of PAD Combination by AHCT in MM

Who this might be right for
Multiple Myeloma
Cooperative Study Group A for Hematology 43
Early research (Phase 1)Looking for participantsNCT04771572
What this trial is testing

Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.

Who this might be right for
Non Hodgkin LymphomaRichter TransformationMultiple Myeloma+10 more
Newave Pharmaceutical Inc 100
Very early researchNot Yet RecruitingNCT07399444
What this trial is testing

A Clinical Study to Evaluate LVIVO-TaVec400 for the Treatment of Relapsed/Refractory Multiple Myeloma（LB2505-0001）

Who this might be right for
Multiple Myeloma (MM)
Institute of Hematology & Blood Diseases Hospital, China 38
Testing effectiveness (Phase 2)Study completedNCT01521533
What this trial is testing

NOX-A12 in Combination With Bortezomib and Dexamethasone in Relapsed Multiple Myeloma

Who this might be right for
Multiple Myeloma
TME Pharma AG 28
Not applicableNot Yet RecruitingNCT07783607
What this trial is testing

MM-CARE: Cardiovascular Risk Assessment in Adults With Multiple Myeloma

Who this might be right for
Multiple MyelomaHeart Disease Risk Factors
University of Vermont Medical Center 33
Next Page